Context Therapeutics, Inc. (CNTX)
0.3042
+0.01
(+1.74%)
USD |
NASDAQ |
Oct 09, 16:00
0.29
-0.01
(-4.67%)
After-Hours: 20:00
Context Therapeutics Price to Book Value : 0.7322 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 0.7322 |
| October 08, 2026 | 0.7197 |
| October 07, 2026 | 0.7524 |
| October 06, 2026 | 0.7746 |
| October 05, 2026 | 0.8099 |
| October 02, 2026 | 0.7454 |
| October 01, 2026 | 0.7568 |
| September 30, 2026 | 0.7231 |
| September 29, 2026 | 0.7678 |
| September 28, 2026 | 0.7854 |
| September 25, 2026 | 0.8321 |
| September 24, 2026 | 0.8932 |
| September 23, 2026 | 0.9209 |
| September 22, 2026 | 0.9366 |
| September 21, 2026 | 0.9017 |
| September 18, 2026 | 0.886 |
| September 17, 2026 | 0.9228 |
| September 16, 2026 | 0.9122 |
| September 15, 2026 | 0.8771 |
| September 14, 2026 | 0.8448 |
| September 11, 2026 | 0.8434 |
| September 10, 2026 | 0.8819 |
| September 09, 2026 | 0.8906 |
| September 08, 2026 | 0.9057 |
| September 04, 2026 | 0.8706 |
| Date | Value |
|---|---|
| September 03, 2026 | 0.8737 |
| September 02, 2026 | 0.873 |
| September 01, 2026 | 0.8769 |
| August 31, 2026 | 0.938 |
| August 28, 2026 | 0.9236 |
| August 27, 2026 | 1.002 |
| August 26, 2026 | 1.020 |
| August 25, 2026 | 1.048 |
| August 24, 2026 | 1.120 |
| August 21, 2026 | 1.204 |
| August 20, 2026 | 1.251 |
| August 19, 2026 | 1.173 |
| August 18, 2026 | 1.195 |
| August 17, 2026 | 1.276 |
| August 14, 2026 | 1.259 |
| August 13, 2026 | 1.219 |
| August 12, 2026 | 1.131 |
| August 11, 2026 | 1.121 |
| August 10, 2026 | 1.089 |
| August 07, 2026 | 1.165 |
| August 06, 2026 | 1.213 |
| August 05, 2026 | 1.668 |
| August 04, 2026 | 1.497 |
| August 03, 2026 | 1.454 |
| July 31, 2026 | 1.443 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck & Co., Inc. | 8.572 |
| ANI Pharmaceuticals, Inc. | 2.842 |
| Corcept Therapeutics, Inc. | 18.53 |
| Veru, Inc. | 1.478 |
| Johnson & Johnson | 7.410 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0265 |
| Price | 0.3042 |
| Earnings Yield | -160.4% |
| Market Cap | 27.95M |
| PEGY Ratio | -0.0265 |